Bank of America’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.65M Buy
965,814
+34,906
+4% +$278K ﹤0.01% 3082
2025
Q4
$5.61M Buy
930,908
+529,925
+132% +$3.16M ﹤0.01% 3298
2025
Q3
$2.29M Sell
400,983
-24,718
-6% -$126K ﹤0.01% 4715
2025
Q2
$2.15M Sell
425,701
-45,006
-10% -$241K ﹤0.01% 4714
2025
Q1
$3.05M Buy
470,707
+277,057
+143% +$2.46M ﹤0.01% 4299
2024
Q4
$1.42M Sell
193,650
-142,943
-42% -$1.13M ﹤0.01% 4743
2024
Q3
$2.52M Sell
336,593
-515,181
-60% -$4.47M ﹤0.01% 4383
2024
Q2
$7.58M Sell
851,774
-284,580
-25% -$2.73M ﹤0.01% 3220
2024
Q1
$11.5M Buy
1,136,354
+984,009
+646% +$10M ﹤0.01% 2861
2023
Q4
$1.53M Sell
152,345
-609,960
-80% -$5.57M ﹤0.01% 4634
2023
Q3
$7.14M Buy
762,305
+421,403
+124% +$6.01M ﹤0.01% 3061
2023
Q2
$8.36M Sell
340,902
-268,813
-44% -$6.75M ﹤0.01% 2881
2023
Q1
$14.2M Buy
609,715
+99,862
+20% +$2.55M ﹤0.01% 2473
2022
Q4
$12.9M Buy
509,853
+73,763
+17% +$1.81M ﹤0.01% 2438
2022
Q3
$8.41M Buy
436,090
+239,146
+121% +$6.08M ﹤0.01% 2794
2022
Q2
$5.02M Sell
196,944
-304,235
-61% -$7.1M ﹤0.01% 3395
2022
Q1
$12.9M Buy
501,179
+197,274
+65% +$5.85M ﹤0.01% 2609
2021
Q4
$12.7M Buy
303,905
+118,522
+64% +$4.64M ﹤0.01% 2688
2021
Q3
$8.07M Sell
185,383
-48,291
-21% -$2.09M ﹤0.01% 3080
2021
Q2
$11M Buy
233,674
+54,888
+31% +$2.5M ﹤0.01% 2729
2021
Q1
$9.17M Buy
178,786
+132,998
+290% +$7.17M ﹤0.01% 2810
2020
Q4
$1.23M Buy
45,788
+20,801
+83% +$676K ﹤0.01% 4330
2020
Q3
$858K Sell
24,987
-21,369
-46% -$920K ﹤0.01% 4330
2020
Q2
$1.9M Buy
46,356
+44,631
+2,587% +$1.5M ﹤0.01% 3668
2020
Q1
$59K Buy
1,725
+609
+55% +$16.4K ﹤0.01% 5798
2019
Q4
$14K Buy
+1,116
New +$15K ﹤0.01% 6586

Other funds holding VIR